Patrick A. Mayes

3.9k total citations · 1 hit paper
31 papers, 2.5k citations indexed

About

Patrick A. Mayes is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Patrick A. Mayes has authored 31 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 17 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Patrick A. Mayes's work include Cancer Immunotherapy and Biomarkers (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and CAR-T cell therapy research (6 papers). Patrick A. Mayes is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and CAR-T cell therapy research (6 papers). Patrick A. Mayes collaborates with scholars based in United States, United Kingdom and France. Patrick A. Mayes's co-authors include Axel Hoos, Wafik S. El‐Deiry, Kenneth W. Hance, John M. Maris, David T. Dicker, Kageaki Kuribayashi, M. Celeste Simon, Guoliang Qing, Nicolas Skuli and Gen Sheng Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick A. Mayes

29 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

2014 375 citations Patrick A. Mayes, Jenny Craigen et al. Blood profile →

Peers

Countries citing papers authored by Patrick A. Mayes

Since Specialization

Citations

This map shows the geographic impact of Patrick A. Mayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Mayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Mayes more than expected).

Fields of papers citing papers by Patrick A. Mayes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick A. Mayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Mayes. The network helps show where Patrick A. Mayes may publish in the future.

Co-authorship network of co-authors of Patrick A. Mayes

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick A. Mayes. A scholar is included among the top collaborators of Patrick A. Mayes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick A. Mayes. Patrick A. Mayes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Fluoroalkenes as Dual Inhibitors of Diacylglycerol Kinases Alpha and Zeta (DGKα/ζ) 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Shiquan Qian, Cheng‐Tsung Lai, Kelly Federowicz, Guofeng Zhang, Melissa Chan, David Rodrigues, (unknown), (unknown), Gengjie Yang, Maryanne Covington, Lisa Truong, Michelle Frascella, (unknown), Patrick A. Mayes, (unknown), (unknown), Joshua R. Hummel, Xiaozhao Wang	0
2	723 A phase 1, first-in-human, open-label, multicenter study of INCA32459, a bispecific anti–PD1 and anti–LAG-3 antibody, in patients with select advanced malignancies 2022 ·Regular and Young Investigator Award Abstracts ·Sarina A. Piha‐Paul, Nawel Bourayou, Richard Schaub, (unknown), (unknown), Patrick A. Mayes, Tara C. Gangadhar	1
3	PF558 THE ANTI-BCMA ANTIBODY-DRUG CONJUGATE GSK2857916 DRIVES IMMUNOGENIC CELL DEATH AND IMMUNE-MEDIATED ANTI-TUMOR RESPONSES, AND IN COMBINATION WITH AN OX40 AGONIST POTENTIATES IN VIVO ACTIVITY 2019 ·HemaSphere ·Rocío Montes de, Sabyasachi Bhattacharya, (unknown), (unknown), (unknown), (unknown), (unknown), Laura Seestaller‐Wehr, Dale A. Cooper, (unknown), Lyuben Tsvetkov, Oliver Kepp, (unknown), Christopher B. Hopson, (unknown), Guido Kroemer, Patrick A. Mayes, Christopher A. Shelton, (unknown), Axel Hoos	14
4	Preclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody 2018 ·Annals of Oncology ·Sara Brett, Sapna Yadavilli, Laura Seestaller‐Wehr, Sabyasachi Bhattacharya, (unknown), Meixia Bi, Jane E. Willoughby, (unknown), (unknown), (unknown), (unknown), J. Jing, Ashleigh Hahn, (unknown), (unknown), Jing Yu, Daniel Olive, Mark S. Cragg, Patrick A. Mayes, Axel Hoos	1
5	The promise and challenges of immune agonist antibody development in cancer 2018 ·Nature Reviews Drug Discovery ·Patrick A. Mayes, Kenneth W. Hance, Axel Hoos	276
6	Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma 2016 ·British Journal of Haematology ·Lydia Lee, (unknown), Jennifer C. Paterson, Gaëlle Herledan, Katherine Sully, Laura Seestaller‐Wehr, William Fieles, James Tunstead, (unknown), Fiona Germaschewski, Patrick A. Mayes, Jenny Craigen, Manuel Rodriguez‐Justo, Kwee Yong	132
7	The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4 2015 ·Clinical Cancer Research ·Li Liu, Patrick A. Mayes, Stephen D. Eastman, Hong Shi, Sapna Yadavilli, Tianqian Zhang, Jingsong Yang, Laura Seestaller‐Wehr, Shuyun Zhang, Chris Hopson, Lyuben Tsvetkov, Junping Jing, Shu Zhang, James Smothers, Axel Hoos	352
8	Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway 2015 ·Molecular Cancer ·Joshua E. Allen, Gabriel Krigsfeld, Luv Patel, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry	77
9	Evaluation Of Bcma As a Therapeutic Target In Multiple Myeloma Using An Antibody-Drug Conjugate 2013 ·Blood ·Kwee Yong, Fiona Germaschewski, Manuel Rodriguez‐Justo, (unknown), Lydia Lee, Patrick A. Mayes, Katherine Sully, Laura Seestaller‐Wehr, William Fieles, James Tunstead, (unknown), Jennifer C. Paterson, Gaëlle Herledan, Jenny Craigen	8
10	Mitogen‐activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere‐associated protein E inhibition 2012 ·International Journal of Cancer ·Patrick A. Mayes, Yan Degenhardt, Andrew Wood, (unknown), Sharon J. Diskin, (unknown), Christopher Moy, Richard Wooster, John M. Maris	16
11	ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation 2012 ·Cancer Cell ·Guoliang Qing, Bo Li, Annette Vu, Nicolas Skuli, Zandra E. Walton, Xueyuan Liu, Patrick A. Mayes, David R. Wise, (unknown), John M. Maris, Michael D. Hogarty, M. Celeste Simon	303
12	Overcoming Hypoxia-Induced Apoptotic Resistance through Combinatorial Inhibition of GSK-3β and CDK1 2011 ·Cancer Research ·Patrick A. Mayes, Nathan G. Dolloff, Colin J. Daniel, (unknown), Lori S. Hart, Kageaki Kuribayashi, Joshua E. Allen, David Jee, Jay F. Dorsey, Yingqiu Y. Liu, David T. Dicker, J. Martin Brown, Emma E. Furth, Peter S. Klein, Rosalie C. Sears, Wafik S. El‐Deiry	27
13	Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation 2011 ·Science Translational Medicine ·Nathan G. Dolloff, Patrick A. Mayes, Lori S. Hart, David T. Dicker, Robin Humphreys, Wafik S. El‐Deiry	35
14	RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma 2011 ·Proceedings of the National Academy of Sciences ·Kristina A. Cole, Jonathan H. Huggins, Michael P. LaQuaglia, (unknown), Mike R. Russell, Kristopher R. Bosse, Sharon J. Diskin, Edward F. Attiyeh, Rachel Sennett, Geoffrey T. Norris, Marci Laudenslager, Andrew Wood, Patrick A. Mayes, Jayanti Jagannathan, Cynthia Winter, Yaël P. Mossé, John M. Maris	194
15	Serial Transcriptome Analysis and Cross-Species Integration Identifies Centromere-Associated Protein E as a Novel Neuroblastoma Target 2010 ·Cancer Research ·Naomi Balamuth, Andrew Wood, Qun Wang, Jayanti Jagannathan, Patrick A. Mayes, Zhe Zhang, Zhongxue Chen, Eric Rappaport, Joshua Courtright, Bruce Pawel, Barbara L. Weber, Richard Wooster, Eric Sekyere, Glenn M. Marshall, John M. Maris	41
16	Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1α 2010 ·Cancer Research ·Guoliang Qing, Nicolas Skuli, Patrick A. Mayes, Bruce Pawel, Daniel Martínez, John M. Maris, M. Celeste Simon	128
17	Abstract 3867: Understanding the neuroblastoma predisposition signal at chromosome 2q35: Identification of the β-BARD1 isoform as an oncogenic driver 2010 ·Cancer Research ·Kristopher R. Bosse, Sharon J. Diskin, Kristina A. Cole, Patrick A. Mayes, Cynthia Winter, Maura Diamond, Marci Laudenslager, Edward F. Attiyeh, Geoffrey T. Norris, Yaël P. Mossé, Mario Capasso, Marcella Devoto, Eric Rappaport, (unknown), John M. Maris	1
18	TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death 2008 ·Cancer Biology & Therapy ·Kageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, Jing Xu, Patrick A. Mayes, David T. Dicker, Gen Sheng Wu, Wafik S. El‐Deiry	90
19	What are caspases 3 and 7 doing upstream of the mitochondria? 2006 ·Cancer Biology & Therapy ·Kageaki Kuribayashi, Patrick A. Mayes, Wafik S. El‐Deiry	119
20	Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment 2005 ·Cancer Biology & Therapy ·Patrick A. Mayes, (unknown), M. Ricci, John P. Plastaras, David T. Dicker, Wafik S. El‐Deiry	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact